| Avamere Transitional Care And Rehab-malley | |
| 401 Malley Dr, Northglenn, Colorado 80233 | |
| (303) 452-4700 | |
| Name | Avamere Transitional Care And Rehab-malley |
|---|---|
| Location | 401 Malley Dr, Northglenn, Colorado |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 162 |
| Occupancy Rate | 76.54% |
| Medicare ID (CCN) | 065196 |
| Legal Business Name | Northglenn Operations Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1194445114 |
| Organization Name | SIDEWINDER HEALTHCARE, INC. |
| Doing Business As | MALLEY TRANSITIONAL CARE CENTER |
| Address | 401 Malley Dr, Northglenn, CO 80233 |
| Phone Number | 303-452-4700 |
News Archive
The researchers trawled a surveillance database used for patients in receipt of Medicare funding for health care, to identify patients aged 65 and older, who had been diagnosed with liver cancer.
Genta Incorporated announced today the presentation of combined data on early endpoints from the Company's randomized Phase 3 trials of Genasense® (oblimersen sodium) Injection plus chemotherapy in patients with advanced melanoma. The presentation included a "pooled analysis" that assessed combined efficacy results for the endpoints of overall response and progression-free survival from both studies. The data were presented today at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL.
In order to fulfill the mission of protecting life and health, and to inherit the advanced scientific technologies created by Dr. Rongxiang Xu in his lifetime and his spirit of healing the wounded and rescuing the dying, the Global Conference for Collaboration and Development on Regenerative Life Science cosponsored by The Chinese Red Cross Foundation and Beijing MEBO Institute for Burns, Wounds and Ulcers will be held in the Great Hall of the People in Beijing on Jan. 6, 2016.
A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.
› Verified 2 days ago
| NPI Number | 1205610938 |
| Organization Name | SIDEWINDER HEALTHCARE, INC. |
| Address | 401 Malley Dr, Northglenn, CO 80233 |
| Phone Number | 303-542-4700 |
News Archive
The researchers trawled a surveillance database used for patients in receipt of Medicare funding for health care, to identify patients aged 65 and older, who had been diagnosed with liver cancer.
Genta Incorporated announced today the presentation of combined data on early endpoints from the Company's randomized Phase 3 trials of Genasense® (oblimersen sodium) Injection plus chemotherapy in patients with advanced melanoma. The presentation included a "pooled analysis" that assessed combined efficacy results for the endpoints of overall response and progression-free survival from both studies. The data were presented today at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL.
In order to fulfill the mission of protecting life and health, and to inherit the advanced scientific technologies created by Dr. Rongxiang Xu in his lifetime and his spirit of healing the wounded and rescuing the dying, the Global Conference for Collaboration and Development on Regenerative Life Science cosponsored by The Chinese Red Cross Foundation and Beijing MEBO Institute for Burns, Wounds and Ulcers will be held in the Great Hall of the People in Beijing on Jan. 6, 2016.
A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.
› Verified 2 days ago
| NPI Number | 1528328135 |
| Organization Name | KINDRED NURSING CENTERS WEST, LLC |
| Doing Business As | KINDRED TRANSITIONAL CARE AND REHABILITATION-MALLEY |
| Address | 401 Malley Dr, Northglenn, CO 80233 |
| Phone Number | 303-452-4700 |
News Archive
The researchers trawled a surveillance database used for patients in receipt of Medicare funding for health care, to identify patients aged 65 and older, who had been diagnosed with liver cancer.
Genta Incorporated announced today the presentation of combined data on early endpoints from the Company's randomized Phase 3 trials of Genasense® (oblimersen sodium) Injection plus chemotherapy in patients with advanced melanoma. The presentation included a "pooled analysis" that assessed combined efficacy results for the endpoints of overall response and progression-free survival from both studies. The data were presented today at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL.
In order to fulfill the mission of protecting life and health, and to inherit the advanced scientific technologies created by Dr. Rongxiang Xu in his lifetime and his spirit of healing the wounded and rescuing the dying, the Global Conference for Collaboration and Development on Regenerative Life Science cosponsored by The Chinese Red Cross Foundation and Beijing MEBO Institute for Burns, Wounds and Ulcers will be held in the Great Hall of the People in Beijing on Jan. 6, 2016.
A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.
› Verified 2 days ago
| NPI Number | 1699434209 |
| Organization Name | NORTHGLENN OPERATIONS, LLC |
| Doing Business As | AVAMERE TRANSITIONAL CARE AND REHABILITATION-MALLEY |
| Address | 401 Malley Dr, Northglenn, CO 80233 |
| Phone Number | 303-452-4700 |
News Archive
The researchers trawled a surveillance database used for patients in receipt of Medicare funding for health care, to identify patients aged 65 and older, who had been diagnosed with liver cancer.
Genta Incorporated announced today the presentation of combined data on early endpoints from the Company's randomized Phase 3 trials of Genasense® (oblimersen sodium) Injection plus chemotherapy in patients with advanced melanoma. The presentation included a "pooled analysis" that assessed combined efficacy results for the endpoints of overall response and progression-free survival from both studies. The data were presented today at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL.
In order to fulfill the mission of protecting life and health, and to inherit the advanced scientific technologies created by Dr. Rongxiang Xu in his lifetime and his spirit of healing the wounded and rescuing the dying, the Global Conference for Collaboration and Development on Regenerative Life Science cosponsored by The Chinese Red Cross Foundation and Beijing MEBO Institute for Burns, Wounds and Ulcers will be held in the Great Hall of the People in Beijing on Jan. 6, 2016.
A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.
› Verified 2 days ago
| NPI Number | 1780928333 |
| Organization Name | NORTHGLENN OPERATIONS, LLC |
| Address | 401 Malley Dr, Northglenn, CO 80233 |
| Phone Number | 303-452-4700 |
News Archive
The researchers trawled a surveillance database used for patients in receipt of Medicare funding for health care, to identify patients aged 65 and older, who had been diagnosed with liver cancer.
Genta Incorporated announced today the presentation of combined data on early endpoints from the Company's randomized Phase 3 trials of Genasense® (oblimersen sodium) Injection plus chemotherapy in patients with advanced melanoma. The presentation included a "pooled analysis" that assessed combined efficacy results for the endpoints of overall response and progression-free survival from both studies. The data were presented today at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL.
In order to fulfill the mission of protecting life and health, and to inherit the advanced scientific technologies created by Dr. Rongxiang Xu in his lifetime and his spirit of healing the wounded and rescuing the dying, the Global Conference for Collaboration and Development on Regenerative Life Science cosponsored by The Chinese Red Cross Foundation and Beijing MEBO Institute for Burns, Wounds and Ulcers will be held in the Great Hall of the People in Beijing on Jan. 6, 2016.
A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.
› Verified 2 days ago
| NPI Number | 1912679168 |
| Organization Name | NORTHGLENN OPERATIONS, LLC |
| Address | 401 Malley Dr, Northglenn, CO 80233 |
| Phone Number | 303-452-4700 |
News Archive
The researchers trawled a surveillance database used for patients in receipt of Medicare funding for health care, to identify patients aged 65 and older, who had been diagnosed with liver cancer.
Genta Incorporated announced today the presentation of combined data on early endpoints from the Company's randomized Phase 3 trials of Genasense® (oblimersen sodium) Injection plus chemotherapy in patients with advanced melanoma. The presentation included a "pooled analysis" that assessed combined efficacy results for the endpoints of overall response and progression-free survival from both studies. The data were presented today at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL.
In order to fulfill the mission of protecting life and health, and to inherit the advanced scientific technologies created by Dr. Rongxiang Xu in his lifetime and his spirit of healing the wounded and rescuing the dying, the Global Conference for Collaboration and Development on Regenerative Life Science cosponsored by The Chinese Red Cross Foundation and Beijing MEBO Institute for Burns, Wounds and Ulcers will be held in the Great Hall of the People in Beijing on Jan. 6, 2016.
A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The researchers trawled a surveillance database used for patients in receipt of Medicare funding for health care, to identify patients aged 65 and older, who had been diagnosed with liver cancer.
Genta Incorporated announced today the presentation of combined data on early endpoints from the Company's randomized Phase 3 trials of Genasense® (oblimersen sodium) Injection plus chemotherapy in patients with advanced melanoma. The presentation included a "pooled analysis" that assessed combined efficacy results for the endpoints of overall response and progression-free survival from both studies. The data were presented today at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL.
In order to fulfill the mission of protecting life and health, and to inherit the advanced scientific technologies created by Dr. Rongxiang Xu in his lifetime and his spirit of healing the wounded and rescuing the dying, the Global Conference for Collaboration and Development on Regenerative Life Science cosponsored by The Chinese Red Cross Foundation and Beijing MEBO Institute for Burns, Wounds and Ulcers will be held in the Great Hall of the People in Beijing on Jan. 6, 2016.
A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $62326 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.36 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.88 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 53.72 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.2 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.3 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 14.39 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.14 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 94.84 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 14.82 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 72.99 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.16 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 25.31 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.33 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.29 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 95.75 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 60.58 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 73.31 | 82.93 |
News Archive
The researchers trawled a surveillance database used for patients in receipt of Medicare funding for health care, to identify patients aged 65 and older, who had been diagnosed with liver cancer.
Genta Incorporated announced today the presentation of combined data on early endpoints from the Company's randomized Phase 3 trials of Genasense® (oblimersen sodium) Injection plus chemotherapy in patients with advanced melanoma. The presentation included a "pooled analysis" that assessed combined efficacy results for the endpoints of overall response and progression-free survival from both studies. The data were presented today at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL.
In order to fulfill the mission of protecting life and health, and to inherit the advanced scientific technologies created by Dr. Rongxiang Xu in his lifetime and his spirit of healing the wounded and rescuing the dying, the Global Conference for Collaboration and Development on Regenerative Life Science cosponsored by The Chinese Red Cross Foundation and Beijing MEBO Institute for Burns, Wounds and Ulcers will be held in the Great Hall of the People in Beijing on Jan. 6, 2016.
A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.
› Verified 2 days ago
Avamere Transitional Care And Rehab-malley Location: 401 Malley Dr, Northglenn, Colorado 80233 Phone: (303) 452-4700 |